UBS’s The ExOne Company XONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$4.27M Buy
204,400
+14,285
+8% +$436K ﹤0.01% 2180
2014
Q2
$7.53M Sell
190,115
-11,577
-6% -$360K 0.01% 1585
2014
Q1
$7.23M Buy
201,692
+35,523
+21% +$1.7M 0.01% 1519
2013
Q4
$10M Buy
166,169
+78,381
+89% +$4.25M 0.01% 1242
2013
Q3
$3.74M Buy
87,788
+39,101
+80% +$2.45M ﹤0.01% 1974
2013
Q2
$3M Buy
+48,687
New +$2.05M ﹤0.01% 2095

Other funds holding XONE

UBS's XONE Position: Q3 2014 in Review

UBS increased its The ExOne Company (XONE) stake by 7.5% in Q3 2014, buying an estimated $436K and bringing the position to 204,400 shares worth $4.27M. The position accounts for ﹤0.01% of the portfolio, ranked #2180.

UBS first reported a position in XONE in Q2 2013 and has held it in 6 quarters since. The position peaked at $10M in Q4 2013. 88 funds tracked by Wall St. Rank hold XONE as of Q3 2014.

  • UBS held 204,400 shares of The ExOne Company worth $4.27M as of Q3 2014.
  • UBS bought 14,285 The ExOne Company shares in Q3 2014, an estimated $436K.
  • The ExOne Company made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2180 holding.
  • UBS first reported a position in The ExOne Company in Q2 2013 and has held it in 6 quarters since.
  • UBS's The ExOne Company position peaked at $10M in Q4 2013.
  • 88 funds tracked by Wall St. Rank held The ExOne Company as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.